• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Tesla to reopen New York facility to manufacture Medtronic ventilators

Tesla to reopen New York facility to manufacture Medtronic ventilators

March 30, 2020 By Danielle Kirsh

teslaTesla announced that it would reopen its New York production facility to manufacture medical devices instead of solar panels to assist Medtronic (NYSE:MDT) in producing ventilators, according to the Minneapolis/St. Paul Business Journal.

Medtronic CEO Omar Ishrak said in a CNBC interview that the Fridley, Minn.-based company would ramp up ventilator production and is currently making 250 ventilators a week. With the help of Tesla, Medtronic is on track to double capacity and manufacture on a 24/7 basis.

“We’ve increased our capacity significantly — we’ve already doubled it and we’re on the way to doubling it again,” Israk said in the CNBC interview. “Our capacity is going up, we’re making these critical care ventilators which are in very high demand. We’re also opening up with other partners who have come forward. Tesla is one that people have heard about.”

Tesla co-founder and CEO Elon Musk said earlier this month that he had been in a “long engineering discussion” with Medtronic about its ventilators. Musk also said in a Tweet at the time that Tesla would make ventilators in the event of a shortage.

There have been numerous reports of device shortages around the world during the coronavirus pandemic. Several companies have begun to ramp up its production of the devices and companies like car manufacturer GM have modified manufacturing capabilities to produce ventilators.

“One of our ventilators will be made by Tesla and they’re fast on track to make that as well,” Ishrak told CNBC.

Musk last week said in a Tweet that the Buffalo, N.Y. solar panel facility – which told non-essential workers to remain at home – would reopen to produce ventilators.

“Giga New York will reopen for ventilator production as soon as humanly possible. We will do anything in our power to help the citizens of New York,” Musk said in a March 25 Tweet.

Medtronic also this week open-sourced one of its lower level ventilator IPs, allowing startups, investors, manufacturers and academic institutions to ramp up ventilator design and production.

Filed Under: Business/Financial News, Featured, Outsourcing, Respiratory Tagged With: coronavirus, COVID-19, Medtronic, Tesla

More recent news

  • Mount Sinai adopts Flosonics wearable ultrasound device
  • GE HealthCare launches next-gen intraoperative ultrasound
  • Philips launches new point-of-care ultrasound system
  • Medtronic to invest $50M in India Diabetes center
  • Corvia Medical raises $55M as it seeks FDA nod for atrial shunt

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy